Yeon-Jung Kim

Title: Yeon-Jung Kim: Innovator in Universal Influenza Vaccination

Introduction

Yeon-Jung Kim is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of immunization, particularly in developing a universal influenza vaccine. His innovative approach aims to combat diverse strains of influenza A viruses, addressing a critical need in public health.

Latest Patents

Yeon-Jung Kim holds a patent for a T cell-based universal influenza vaccine. This invention includes internal genes capable of preparing against infection by broad hetero-subtypic influenza viruses, thereby providing a defense against unpredictable epidemic influenza. The vaccine is characterized by including at least one CTL epitope and utilizing a plurality of internal genes derived from consensus sequences obtained from bird, pig, and human influenza isolates. This innovative vaccine can achieve broad defense against infections with hetero-subtypic influenza viruses. He has 1 patent to his name.

Career Highlights

Yeon-Jung Kim is affiliated with the Mogam Biotechnology Research Institute, where he continues to advance his research in immunology and vaccine development. His work is pivotal in the ongoing efforts to enhance public health through innovative vaccination strategies.

Collaborations

Some of his notable coworkers include Jin-Won Youn and Ji-Sun Kwon, who contribute to the collaborative research environment at the Mogam Biotechnology Research Institute.

Conclusion

Yeon-Jung Kim's contributions to the field of influenza vaccination exemplify the importance of innovation in public health. His work on a universal influenza vaccine represents a significant advancement in the fight against viral infections.